Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Large Is the Advanced Therapeutics Pharmaceutical Outsourcing Market Expected to Be in 2029?
The size of the advanced therapeutics pharmaceutical outsourcing market has been on a steady upward trajectory in the past few years. Predictions indicate that it will increase from $8.07 billion in 2024 to $8.41 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.2%. This historical growth pattern is attributed to the expansion of biopharmaceutical infrastructure, adherence to regulatory compliance, a surge in the demand for innovative drugs to combat chronic and fatal diseases, enhanced efficiency, and the rising demand for tailored medicine.
In the coming years, the market size for advanced therapeutics pharmaceutical outsourcing is anticipated to experience consistent growth. It is predicted to expand to “$10.21 billion by 2029, with a compound annual growth rate (CAGR) of 5.0%. This growth during the prognosis period can be credited to the growing implementation of cell and gene therapies, elevated focus on mRNA therapies, increasing need for novel treatments, enhanced efficiency and budget-friendly solutions delivered by outsourcing associates and shared innovation. Foreseen trends for this period include technological progression, increasing expertise in advanced therapeutics, climbing pipeline of creative therapies, the merger of advanced technology, as well as accelerated advancements in gene therapy, cell therapy, and mRNA technologies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13768&type=smp
What Are The Contributors To Demand In The Advanced Therapeutics Pharmaceutical Outsourcing Market?
The advanced therapeutics pharmaceutical outsourcing market is projected to experience significant growth, driven by the rising uptake of cell and gene therapies. These groundbreaking treatments that utilise live cells or genetic material to treat or cure diseases are becoming increasingly popular. Pharmaceutical outsourcing in advanced therapeutics offers companies the ability to collaborate with proven, experienced providers in cell and gene therapies, thereby eliminating the need and cost of developing their own expert teams. For instance, Nature, a scientific journal based in the UK, reported in November 2023 that new patient numbers receiving gene therapies are predicted to escalate from 16,244 in 2020 to 94,696 in 2025. Thus, the growing adoption of cell and gene therapies is fuelling the expansion of the advanced therapeutics pharmaceutical outsourcing market.
The advanced therapeutics pharmaceutical outsourcing market covered in this report is segmented –
1) By Service Type: Contract Research Organizations (CROs), Contract Development And Manufacturing Organizations (CDMOs)
2) By Indication: Oncology, Neurology, Cardiology, Infectious Diseases, Other Indications
3) By Therapy: Cell Therapy, Gene Therapy, RNA-based Therapies
4) By Application: Preclinical Services, Clinical Services, Commercial Manufacturing And Packaging
Subsegments:
1) By Contract Research Organizations (CROs): Preclinical Research Services, Clinical Trial Management Services, Regulatory Affairs Services, Data Management And Biostatistics
2) By Contract Development And Manufacturing Organizations (CDMOs): Drug Development Services, Formulation Development, Analytical Testing Services, Commercial Manufacturing Services
What Long-Term Trends Are Likely To Affect The Advanced Therapeutics Pharmaceutical Outsourcing Market?
Leading businesses in the advanced therapeutics pharmaceutical outsourcing sector are honing in on strategic collaborations as a way to deliver dependable services to their clients. These strategic alliances represent cooperative efforts between two or more bodies (usually corporations) intent on realizing shared benefits that they could not attain alone. Take for instance, Lonza, a Swiss manufacturing firm serving the pharmaceutical, biotechnology, and nutrition industries, which joined forces with Context Therapeutics Inc., a biopharmaceutical firm based in the United States that is innovating medicines for solid tumors. This collaboration sees Lonza in charge of appraising manufacturability, the making of genes and cell lines, along with the development of methodologies for the substance and product of the drug, in January 2023.
Who Are The Top-Ranked Companies In The Advanced Therapeutics Pharmaceutical Outsourcing Market Today?
Major companies operating in the advanced therapeutics pharmaceutical outsourcing market report are Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, IQVIA, ICON plc, SGS SA, Lonza Group, Parexel International Corporation, WuXi AppTec, Syneos Health, Catalent Inc., Charles River Laboratories International, Recipharm AB, Croda International Plc, Samsung Biologics, Vetter Pharma International GmbH, Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies, Marken, AGC Biologics, Evotec SE, ProPharma Group, Piramal Pharma Solutions, Corden Pharma International LLC, Novotech Pty Ltd., Cryoport Systems Inc., Cytovance Biologics
How Is Advanced Therapeutics Pharmaceutical Outsourcing Market Adoption Varying Across Different Regions And Sectors?
North America was the largest region in the advanced therapeutics pharmaceutical outsourcing market in 2024. The regions covered in the advanced therapeutics pharmaceutical outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=13768&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
